Prospective Study on the Feasibility and Results of POEM in Idiopathic Achalasia
Launched by ISTITUTO CLINICO HUMANITAS · Oct 3, 2014
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 to 75 years
- • Manometric diagnosis of achalasia
- • Eckardt score more than 3
- • Informed consent
- Exclusion Criteria:
- • Increased surgical risk for important comorbidities,
- • Pseudoachalasia
- • Mega-esophagus (more than 7 cm) and or sigmoid esophagus,
- • Previous esophageal or gastric surgery (with the exception of gastric perforation)
- • Inability of completing the questionnarie
- • Inability to keep a commitment for follow-up
- • Esophageal diverticulum
Trial Officials
Alessandro Repici, MD
Principal Investigator
Istituto Clinico Humanitas
About Istituto Clinico Humanitas
Istituto Clinico Humanitas is a leading clinical research organization based in Italy, dedicated to advancing medical science through innovative clinical trials and research initiatives. With a strong emphasis on patient-centered care and cutting-edge methodologies, the institute collaborates with various stakeholders in the healthcare sector to develop and evaluate new therapies and treatment protocols. Its multidisciplinary team of experts is committed to ensuring the highest standards of ethical practice and scientific rigor, contributing to significant advancements in medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rozzano, Milano, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
